183 related articles for article (PubMed ID: 25592047)
1. Interactions of the renin-angiotensin system in colorectal cancer and metastasis.
Childers WK
Int J Colorectal Dis; 2015 Jun; 30(6):749-52. PubMed ID: 25592047
[TBL] [Abstract][Full Text] [Related]
2. The Therapeutic Potential of Angiotensin-converting Enzyme and Angiotensin Receptor Inhibitors in the Treatment of Colorectal Cancer: Rational Strategies and Recent Progress.
Asgharzadeh F; Hassanian SM; Ferns GA; Khazaei M; Hasanzadeh M
Curr Pharm Des; 2018; 24(39):4652-4658. PubMed ID: 30636592
[TBL] [Abstract][Full Text] [Related]
3. Regulation of colorectal cancer cell epithelial to mesenchymal transition by the renin angiotensin system.
Nguyen L; Ager EI; Neo J; Christophi C
J Gastroenterol Hepatol; 2016 Oct; 31(10):1773-1782. PubMed ID: 26849969
[TBL] [Abstract][Full Text] [Related]
4. Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.
Neo JH; Ager EI; Angus PW; Zhu J; Herath CB; Christophi C
BMC Cancer; 2010 Apr; 10():134. PubMed ID: 20380732
[TBL] [Abstract][Full Text] [Related]
5. The renin angiotensin system regulates Kupffer cells in colorectal liver metastases.
Wen SW; Ager EI; Neo J; Christophi C
Cancer Biol Ther; 2013 Aug; 14(8):720-7. PubMed ID: 23792575
[TBL] [Abstract][Full Text] [Related]
6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
7. Manipulating the angiotensin system--new approaches to the treatment of solid tumours.
Ino K; Shibata K; Kajiyama H; Nawa A; Nomura S; Kikkawa F
Expert Opin Biol Ther; 2006 Mar; 6(3):243-55. PubMed ID: 16503734
[TBL] [Abstract][Full Text] [Related]
8. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
Schalekamp MA; Derkx FH; van den Meiracker AH
J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
[TBL] [Abstract][Full Text] [Related]
9. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
Wolf G; Ritz E
Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
[TBL] [Abstract][Full Text] [Related]
11. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
Mori J; Zhang L; Oudit GY; Lopaschuk GD
J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
[TBL] [Abstract][Full Text] [Related]
12. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
Henriksen EJ; Prasannarong M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
[TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin system: importance in physiology and pathology.
Ferrario CM
J Cardiovasc Pharmacol; 1990; 15 Suppl 3():S1-5. PubMed ID: 1691411
[TBL] [Abstract][Full Text] [Related]
14. Activation of the AT1R/HIF-1 α /ACE axis mediates angiotensin II-induced VEGF synthesis in mesenchymal stem cells.
Liu C; Zhang JW; Hu L; Song YC; Zhou L; Fan Y; Zhu HY; Wang Y; Li QP
Biomed Res Int; 2014; 2014():627380. PubMed ID: 25401104
[TBL] [Abstract][Full Text] [Related]
15. Role of angiotensin II in diabetic nephropathy.
Kennefick TM; Anderson S
Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
[TBL] [Abstract][Full Text] [Related]
16. [Adipose tissue renin-angiotensin system in obese].
Yasue S; Ebihara K; Nakao K
Nihon Rinsho; 2012 Sep; 70(9):1550-5. PubMed ID: 23012802
[TBL] [Abstract][Full Text] [Related]
17. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
18. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; OyarzĂșn A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
19. Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells.
Yoshiji H; Yoshii J; Ikenaka Y; Noguchi R; Yanase K; Tsujinoue H; Imazu H; Fukui H
Int J Oncol; 2002 Jun; 20(6):1227-31. PubMed ID: 12012003
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the renin-angiotensin system inhibits growth of colorectal cancer liver metastases in the regenerating liver.
Koh SL; Ager EI; Costa PL; Malcontenti-Wilson C; Muralidharan V; Christophi C
Clin Exp Metastasis; 2014 Apr; 31(4):395-405. PubMed ID: 24442969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
